IRIS

MARASCA, CLAUDIO

MARASCA, CLAUDIO  

Dipartimento di Medicina clinica e Chirurgia  

Mostra records
Risultati 1 - 20 di 103 (tempo di esecuzione: 0.061 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy 1.1 Articolo in rivista 2022 Marasca, Claudio; Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Fabbrocini, Gabriella
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab" 1.1 Articolo in rivista 2023 Martora, Fabrizio; Fabbrocini, Gabriella; Marasca, Claudio; Battista, Teresa; Megna, Matteo
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? 1.1 Articolo in rivista 2023 Barrea, Luigi; Cacciapuoti, Sara; Megna, Matteo; Verde, Ludovica; Marasca, Claudio; Vono, Rosa; Camajani, Elisabetta; Colao, Annamaria; Savastano, Silvia; Fabbrocini, Gabriella; Muscogiuri, Giovanna
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al 1.1 Articolo in rivista 2023 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis 1.1 Articolo in rivista 2023 Martora, Fabrizio; Marasca, Claudio; Picone, Vincenzo; Fornaro, Luigi; Megna, Matteo; Fabbrocini, Gabriella
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 1.1 Articolo in rivista 2023 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 1.1 Articolo in rivista 2022 Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature 1.1 Articolo in rivista 2022 Martora, Fabrizio; Battista, Teresa; Marasca, Claudio; Genco, Lucia; Fabbrocini, Gabriella; Potestio, Luca
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa' 1.1 Articolo in rivista 2022 Martora, Fabrizio; Marasca, Claudio; Battista, Teresa; Fabbrocini, Gabriella; Ruggiero, Angelo
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects 1.1 Articolo in rivista 2022 Martora, Fabrizio; Fornaro, Luigi; Picone, Vincenzo; Marasca, Dario; Gargiulo, Maurizio; Annunziata, Maria Carmela; Fabbrocini, Gabriella; Marasca, Claudio
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 1.1 Articolo in rivista 2022 Martora, Fabrizio; Battista, Teresa; Fornaro, Luigi; Fabbrocini, Gabriella; Megna, Matteo; Picone, Vincenzo; Marasca, Claudio
Step by step surgery for Hidradenitis Suppurativa 1.1 Articolo in rivista 2022 Di Guida, Adriana; Patrizia, Forgione; Fornaro, Luigi; Marasca, Dario; Fabbrocini, Gabriella; Marasca, Claudio
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 1.7 Commento, erratum, replica e simili 2022 Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F
Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment 1.1 Articolo in rivista 2022 Ruggiero, Angelo; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
Hair removal and deodorants in hidradenitis suppurativa: an online survey on patients' habits 1.1 Articolo in rivista 2022 Lauro, Wanda; Capasso, Gianmarco; Fabbrocini, Gabriella; Marasca, Claudio
Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al 1.7 Commento, erratum, replica e simili 2022 Martora, F; Fabbrocini, G; Nappa, P; Marasca, C; Patruno, C; Scalvenzi, M; Napolitano, M
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience' 1.7 Commento, erratum, replica e simili 2022 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Potestio, Luca
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? 1.1 Articolo in rivista 2022 Ruggiero, Angelo; Marasca, Claudio; Fabbrocini, Gabriella; Villani, Alessia; Martora, Fabrizio
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa 1.1 Articolo in rivista 2020 Marasca, Claudio; Marasca, Dario; Megna, Matteo; Annunziata, MARIA CARMELA; Fabbrocini, Gabriella
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?' 1.1 Articolo in rivista 2022 Martora, Fabrizio; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo